UTAH MEDICAL PRODUCTS INC (UTMD) Stock Overview
USA - NASDAQ:UTMD - US9174881089 - Common Stock
UTMD Key Statistics, Chart & Performance
The current stock price of UTMD is 60.45 USD. In the past month the price decreased by -4.06%. In the past year, price decreased by -5.72%.
UTMD Latest News, Press Relases and Analysis
UTMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 25.09 | 37.86B | ||
| COO | COOPER COS INC/THE | 18.66 | 14.91B | ||
| SOLV | SOLVENTUM CORP | 11.99 | 12.64B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.48 | 9.87B | ||
| BLCO | BAUSCH + LOMB CORP | 37.21 | 5.53B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.99 | 4.98B | ||
| LNTH | LANTHEUS HOLDINGS INC | 9.03 | 3.92B | ||
| ICUI | ICU MEDICAL INC | 16.09 | 2.99B | ||
| XRAY | DENTSPLY SIRONA INC | 7.58 | 2.59B | ||
| HAE | HAEMONETICS CORP/MASS | 11.01 | 2.47B | ||
| UFPT | UFP TECHNOLOGIES INC | 23.32 | 1.55B | ||
| ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.43B |
Related stock screener links
About UTMD
Company Profile
Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Company Info
UTAH MEDICAL PRODUCTS INC
7043 S 300 West
Midvale UTAH 84047 US
CEO: Kevin L. Cornwell
Employees: 161
Phone: 18015215301
UTAH MEDICAL PRODUCTS INC / UTMD FAQ
What is the stock price of UTAH MEDICAL PRODUCTS INC today?
The current stock price of UTMD is 60.45 USD. The price decreased by -0.53% in the last trading session.
What is the ticker symbol for UTAH MEDICAL PRODUCTS INC stock?
The exchange symbol of UTAH MEDICAL PRODUCTS INC is UTMD and it is listed on the Nasdaq exchange.
On which exchange is UTMD stock listed?
UTMD stock is listed on the Nasdaq exchange.
What is UTAH MEDICAL PRODUCTS INC worth?
UTAH MEDICAL PRODUCTS INC (UTMD) has a market capitalization of 194.04M USD. This makes UTMD a Micro Cap stock.
How many employees does UTAH MEDICAL PRODUCTS INC have?
UTAH MEDICAL PRODUCTS INC (UTMD) currently has 161 employees.
What are the support and resistance levels for UTAH MEDICAL PRODUCTS INC (UTMD) stock?
UTAH MEDICAL PRODUCTS INC (UTMD) has a support level at 58.23 and a resistance level at 60.96. Check the full technical report for a detailed analysis of UTMD support and resistance levels.
Should I buy UTAH MEDICAL PRODUCTS INC (UTMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of UTMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of UTMD, evaluating the profitability, health, valuation and growth aspects
- UTAH MEDICAL PRODUCTS INC (UTMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- UTAH MEDICAL PRODUCTS INC (UTMD) Sales and EPS estimates to see what analysts future expectations are.
- UTAH MEDICAL PRODUCTS INC (UTMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- UTAH MEDICAL PRODUCTS INC (UTMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- UTAH MEDICAL PRODUCTS INC (UTMD) Stock Chart to make your own analysis
- UTAH MEDICAL PRODUCTS INC (UTMD) Latest news and press-releases to stay up to date.
Does UTAH MEDICAL PRODUCTS INC (UTMD) stock pay dividends?
UTAH MEDICAL PRODUCTS INC (UTMD) has a dividend yield of 2.03%. The yearly dividend amount is currently 1.22. Check the full fundamental report for a detailed analysis of UTMD dividend history, reliability and sustainability.
When does UTAH MEDICAL PRODUCTS INC (UTMD) report earnings?
UTAH MEDICAL PRODUCTS INC (UTMD) will report earnings on 2025-10-28.
What is the Price/Earnings (PE) ratio of UTAH MEDICAL PRODUCTS INC (UTMD)?
The PE ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 16.16. This is based on the reported non-GAAP earnings per share of 3.74 and the current share price of 60.45 USD. Check the full fundamental report for a full analysis of the valuation metrics for UTMD.
What is the Short Interest ratio of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
The outstanding short interest for UTAH MEDICAL PRODUCTS INC (UTMD) is 3.83% of its float. Check the ownership tab for more information on the UTMD short interest.
UTMD Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to UTMD. When comparing the yearly performance of all stocks, UTMD is a bad performer in the overall market: 67.86% of all stocks are doing better.
UTMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to UTMD. Both the health and profitability get an excellent rating, making UTMD a very profitable company, without any liquidiy or solvency issues.
UTMD Financial Highlights
Over the last trailing twelve months UTMD reported a non-GAAP Earnings per Share(EPS) of 3.74. The EPS decreased by -13.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 32.33% | ||
| ROA | 10.39% | ||
| ROE | 10.68% | ||
| Debt/Equity | 0 |